202
Views
3
CrossRef citations to date
0
Altmetric
Brief Report

NEK1 and GRN mutations coexist in a sporadic Chinese Hui descent ALS patient

ORCID Icon, , , , , & show all
Pages 624-626 | Received 10 Apr 2020, Accepted 03 Jun 2020, Published online: 08 Aug 2020
 

Abstract

We describe a sporadic amyotrophic lateral sclerosis (ALS) patient who presented rapid progress of muscle weakness and died of respiratory failure one and a half years after onset. Genetic analysis revealed a novel ALS-causing gene NEK1 nonsense mutation p.K1210* and a known pathogenic frontotemporal lobar degeneration (FTD)-causing gene GRN mutation p.C139R. It is rare for ALS patients to carry two different pathogenic mutations simultaneously. The individual only had typically motor neuron dysfunction without any related cognitive symptoms. GRN p.C139R mutation is linked to various clinical phenotypes that include FTD and Alzheimer’s disease (AD). The case carrying two different gene mutations expands our understanding of ALS genetics.

Declaration of interest

The authors have no conflicts of interest to declare.

Additional information

Funding

This study is supported by the National Natural Science Foundation of China under Grant [number 81560226]; National Natural Science Foundation of China under Grant [number 81860250].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 478.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.